EP2464329A2 - Zusammensetzungen zur haarpflege enthaltend rambutanöl - Google Patents
Zusammensetzungen zur haarpflege enthaltend rambutanölInfo
- Publication number
- EP2464329A2 EP2464329A2 EP10731509A EP10731509A EP2464329A2 EP 2464329 A2 EP2464329 A2 EP 2464329A2 EP 10731509 A EP10731509 A EP 10731509A EP 10731509 A EP10731509 A EP 10731509A EP 2464329 A2 EP2464329 A2 EP 2464329A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- oil
- alcohol
- weight
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Definitions
- compositions for hair care containing rambutan oil.
- Particular compositions for hair care contain in addition to rambutan oil other active ingredients such as cationic polymers and / or proteins.
- keratinic fibers especially of human hair
- human hair is today treated in a variety of ways with hair cosmetic preparations.
- the known active ingredients can not cover all needs sufficiently. There is therefore still a need for active ingredients or combinations of active substances for cosmetic products with good care properties and good biodegradability. Furthermore, the compatibility of the cosmetic compositions is an extremely important criterion.
- Detergents for skin and hair not only have to have a good cleansing power, but should continue to be well tolerated by the skin and mucous membranes and not lead to excessive defatting or skin dryness even with frequent use.
- modern compositions are expected to have a significantly improved condition of the skin relative to the moisture balance of the dry skin. The wetting of skin and hair with impurities should be significantly delayed.
- the feeling of skin and hair after cosmetic treatments is an essential criterion, whether the appropriate composition is perceived by the consumer as pleasant.
- the sensor technology and in particular the feel of a composition are thus essential effects that the consumer can experience. We are therefore looking for precisely those compositions which not only care for the skin and hair but also, through their sensory and haptic properties in particular, noticeably and tangibly change the surface of the skin and hair.
- Natural oils such as soybean oil or almond oil
- their ethoxylates for example ethoxylated soybean oil
- sufficient conditioning insufficient combability of the wet and dry fibers, too low gloss is achieved.
- almond oil or paraffin oil can not be incorporated into the formulations in a stable manner.
- the object of the present invention is to significantly improve the conditioning properties and the gloss of keratinic fibers in the application of surfactant agents and also to give them additionally sensory, especially tactile effects.
- a first subject of the present invention is therefore a composition for the treatment of keratinic fibers, in particular human hair, containing
- compositions according to the invention comprising the active substance complex according to the invention are distinguished by a significantly improved state of the keratinic fibers with respect to the moisture balance of the keratinic fibers.
- Active ingredient complex (A) is spoken, this statement refers to the ingredients contained in the inventive compositions a) and b).
- Hair treatment compositions according to the present invention are, for example, hair shampoos,
- Hair conditioners conditioning shampoos, hair conditioners, hair conditioners, hair wraps,
- Hair tonics hair dye shampoos or their combinations.
- Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.
- Suitable cosmetic vehicles according to the invention are in particular O / W, W / O and W / O / W.
- Emulsions in the form of creams or gels or surfactant-containing foaming solutions such as shampoos, foam aerosols or other preparations, in particular for the
- the cosmetic carriers may in particular be aqueous or aqueous-alcoholic.
- An aqueous cosmetic carrier contains at least 50% by weight of water.
- aqueous-alcoholic cosmetic carriers include aqueous solutions containing from 3 to 70% by weight of a C 1 -C 6 -alcohol, in particular methanol,
- Ethanol or propanol isopropanol, butanol, isobutanol, tert-butanol, n-pentanol, iso-pentanols, n-hexanol, isohexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or
- agents according to the invention may additionally contain further organic radicals, 1, 6-hexanediol to understand.
- the agents according to the invention may additionally contain further organic radicals
- Solvents such as, for example, methoxybutanol, benzyl alcohol, ethyl diglycol or 1, 2
- Propylene glycol included. Preference is given to all water-soluble organic solvents.
- compositions according to the invention contain at least 0.01 to 10% by weight, preferably 0.01 to 7.5% by weight and in particular 0.01 to 5.0% by weight of rambutan oil.
- Rambutan oil is a natural oil. Rambutan is also known as Nepelium Lappaceum and with
- Lychee related Like lychee, rambutan is found mainly in Southeast Asia. The
- Rambutan oil is in the compositions of the invention in an amount based on the
- Surfactants are used as ingredient b), with both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants being suitable in principle. The selection depends on the type of product. In the case of a shampoo, in particular at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance is chosen. These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances. The ratio between anionic and zwitterionic surface-active substances is between 10: 1 and 1: 5. The ratio is particularly preferably 5: 1 to 1: 2.
- Suitable anionic surfactants (tanion) in preparations according to the invention are all anionic surfactants suitable for use on the human body. Typical examples of anionic surfactants are:
- Sulfobernsteinklamono- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.
- Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms are alpha-sulfofatty acids having 8 to 30 carbon atoms.
- alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 carbon atoms and x 0 or 1 to 12, hydroxysulfonates substantially corresponding to at least one of the following two formulas or mixtures thereof and salts thereof,
- R 1 is preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms
- R 2 is hydrogen, a radical (CH 2 CH 2 O) n R 2 or X, n is from 1 to 10 and X is hydrogen, an alkali metal radical or alkaline earth metal or NR 3 R 4 R 5 R 6 , where R 3 to R 6 independently of one another represent hydrogen or a C 1 to C 4 hydrocarbon radical,
- RCO-- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 C atoms
- Alk for CH 2 CH 2 , CHCH 3 CH 2 and / or CH 2 CHCH 3
- n for numbers of 0 , 5 to 5 and M is a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or ammonium ion, such as + NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another represent hydrogen or a C1 to C4 hydrocarbon radical
- R 8 CO is a linear or branched acyl radical having 6 to 22 carbon atoms
- x, y and z are in total 0 or numbers of 1 to 30, preferably 2 to 10
- X is an alkali or alkaline earth metal.
- monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts.
- monoglyceride sulfates are used, in which R 8 CO is a linear acyl radical having 8 to 18 carbon atoms,
- Amide ether carboxylic acids R 1 -CO-NR 2 -CH 2 CH 2 -O- (CH 2 CH 2 O) n CH 2 COOM, with R 1 as the straight-chain or branched alkyl or alkenyl radical having a number of carbon atoms in the chain of 2 to 30, n is an integer from 1 to 20, and R 2 is hydrogen, methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl or iso-butyl, and M is Hydrogen or a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or an ammonium ion, such as + NR 3 R 4 R 5 R 6 , where R 3 to R 6 are each independently hydrogen or a C1 to C4 hydrocarbon radical.
- Such products are available, for example, by the company Chem Y under the product Akypo ®.
- Condensation products of a water-soluble salt of a water-soluble protein hydrolyzate with a C8-C30 fatty acid are available under the trademark Lamepon® ®, Maypon ®, Gluadin® ®, Hostapon® ® KCG or Amisoft ® long been commercially.
- the mild anionic surfactants contain polyglycol ether chains, it is particularly preferred that they have a narrow homolog distribution. Further, in the case of mild anionic surfactants having polyglycol ether units, it is preferable that the number of glycol ether groups is 1 to 20, preferably 2 to 15, more preferably 2 to 12. Particularly mild anionic surfactants having polyglycol ether groups with no restricted homolog distribution can be obtained, for example on the one hand the number of polyglycol ether groups is 4 to 12 and Zn or Mg ions are selected as the counterion. One example is the commercial product Texapon.RTM ® ASV.
- Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyl dimethylammonium glycinate, and 2-alkyl 3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
- a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
- Ampholytic surfactants are understood as meaning those surface-active compounds which are capable of forming internal salts.
- suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkylimino-dipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group.
- amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
- Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
- Nonionic surfactants are for example Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 6 to 30 carbon atoms, the fatty alcohol polyglycol ethers or the Fettalkoholpolypropylenglykolether or mixed fatty alcohol polyethers,
- R 1 CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms
- R 2 is hydrogen or methyl
- R 3 is a linear or branched alkyl radical having 1 to 4 carbon atoms and w is a number from 1 to 20 stands, amine oxides,
- R 1 O [CH 2 CH (CH 3 ) O] x (CH 2 CHR 2 O) y [CH 2 CH (OH) R 3 ] z with R 1 being a linear or branched, saturated or unsaturated alkyl and / or alkenyl radical having 2 to 30 C atoms
- R 2 is hydrogen, a methyl, ethyl, propyl or iso-propyl radical
- R 3 is a linear or branched alkyl radical having 2 to 30 C atoms, x standing for 0 or a number from 1 to 20, Y for a number from 1 to 30 and z standing for the number 1, 2, 3, 4 or 5.
- Fatty acid amide polyglycol ethers Fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, Mixed ethers or mixed formals and polysorbates.
- At least one quaternary imidazoline compound i. a compound having a positively charged imidazoline ring.
- the formula I shown below shows the structure of these compounds.
- the radicals R and R1 are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30 carbon atoms.
- the preferred compounds of the formula I contain for R and R1 in each case the same hydrocarbon radical.
- the chain length of the radicals R and R1 is preferably 12 carbon atoms. Particular preference is given to compounds having a chain length of at least 16 carbon atoms and very particularly preferably having at least 20 carbon atoms. A most preferred compound of formula I has a chain length of 21 carbon atoms.
- a product of this chain length is, for example, under the name quaternium-91 or trade names Crodazosoft ® DBQ which, in addition quaternium-91 further includes Cetrimonium Methosulfate and Cetearyl Alcohol, and Crodazosoft ® SCQ which, in addition quaternium-91 further including the PPG-3 benzyl ether myristate , known.
- Suitable counterions are all physiologically compatible counterions, for example methosulfates, halides such as chloride, fluoride, bromide, or even phosphates. Examples according to the invention are available, for example, under the INCII names Quaternium-27, Quaternium-72, Quaternium-83 and Quaternium-91. On Trentzugtesten the commercial products Crodazosoft ® DBQ and Crodazosoft ® SCQ be, or quaternium-91, is used.
- the imidazolines of the formula I are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.05 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight. % contain. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.
- R here stands for a substituted or unsubstituted, branched or straight-chain alkyl or alkenyl radical having 11 to 35 carbon atoms in the chain
- X is - O - or - NR 5 -
- R 1 represents an alkylene group having 2 to 6 C atoms, which may be unsubstituted or substituted, in which case substitution with an -OH or -NH group is preferred in the case of a substitution
- R 2 , R 3 each independently represents an alkyl or hydroxyalkyl group of 1 up to
- R5 is hydrogen or a C1 to C6 straight or branched alkyl or
- Alkenyl radical which may also be substituted by a hydroxy group.
- the compounds are preferably one of the following
- esterquats according to the formula (Tkat1-2) can be used.
- radicals R1, R2 and R3 are each independently and may be the same or different.
- the radicals R1, R2 and R3 mean:
- branched or unbranched alkyl radical having 1 to 4 carbon atoms, which may contain at least one hydroxyl group, or
- aryl or alkaryl radical for example phenyl or benzyl
- the remainder - (A - R4) is contained at least 1 to 3 times.
- n 1 to 200, preferably 1 to 100, particularly preferably 1 to 50, and particularly preferably 1 to 20 with R 5 in the meaning of hydrogen, methyl or ethyl,
- R 6 -O-CO- wherein R 6 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and or 1 to 100 propylene oxide units may be ethoxylated
- R7-C0- wherein R7 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and / or 1 to 100 propylene oxide units can be ethoxylated
- Q is a physiologically acceptable organic or inorganic anion.
- Such products are marketed under the trademarks Rewoquat ®, Stepantex® ®, ® and Dehyquart® Armocare® ®.
- R8 corresponds in its meaning R7.
- Alkyl radicals of 16 to 24 carbon atoms may be included.
- R1, R2 and R3 are each a methyl group and R4 is a saturated, branched or unbranched alkyl radical having a chain length of 16 to 24 carbon atoms.
- R4 is a saturated, branched or unbranched alkyl radical having a chain length of 16 to 24 carbon atoms.
- Examples of compounds of the formula (Tkat1-1) are cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, cetyltrimethylammonium methosulfate,
- compositions according to the invention furthermore comprise at least one amine and / or cationized amine, in particular an amidoamine and / or a cationized amidoamine having the following structural formulas:
- R 1 is an acyl or alkyl radical having 6 to 30 C atoms, which may be branched or unbranched, saturated or unsaturated, and wherein the acyl radical and / or the alkyl radical may contain at least one OH group, and R 2, R 3 and R 4 are each, independently of one another, hydrogen or an alkyl radical having 1 to 4 C
- Atoms which may be the same or different, saturated or unsaturated, and
- n is an integer between 1 and 10.
- R1 is a branched or unbranched, saturated or unsaturated acyl radical with 6 to 30 carbon atoms, which may contain at least one OH group means.
- amidoamines and / or quaternized amidoamines in which R 2, R 3 and / or R 4 in formulas (Tkat7) and / or (Tkat ⁇ ) represent a radical according to the general formula CH 2 CH 2 OR 5, where R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms, hydroxyethyl or hydrogen.
- R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms, hydroxyethyl or hydrogen.
- the preferred size of n in the general formulas (Tkat7) and / or (Tkat ⁇ ) is an integer between 2 and 5.
- the alkyl radical having 1 to 4 carbon atoms of R 2, R 3 and R 4 and / or the alkyl radical having 1 to 4 carbon atoms of RSO 3 " in the general formula (Tkat7) and / or (Tkat ⁇ ) may contain at least one hydroxyl group.
- the alkylamidoamines can both be present as such and converted by protonation in a correspondingly acidic solution into a quaternary compound in the composition. According to the invention, the cationic alkylamidoamines are preferred.
- amidoamines to be used according to the invention are, for example, amidoamines: Witcamine 100 (Witco, INCI name: Cocamidopropyl Dimethylamine), Incromine BB (Croda, INCI name: behenamidopropyl dimethylamine), Mackin 401 (McIntyre, INCI name: isostearylamidopropyl dimethylamine) and other Mackine types, Adogen S1 ⁇ V (Witco, INCI name: Stearylamidopropyl Dimethylamine), and as permanent cationic aminoamines: Rewoquat RTM 50 (Witco Surfactants GmbH, INCI name: Ricinoleamidopropyltrimonium Methosulfate), Empigen CSC (Albright & Wilson, INCI name: Cocamidopropyltrimonium chloride), Swanol Lanoquat DES-50 (Nikko, INCI name: Quatemium-33), Rewoquat DES-50 (Nikko, INCI
- the anion of all cationic compounds is selected from the physiologically acceptable anions.
- these are the halide ions, fluoride, chloride, bromide, sulfate of the general formula RSO 3 " , in which R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, or anionic radicals of organic acids such as maleate, fumarate, oxalate, tartrate, Citrate, lactate or acetate, called.
- the aforementioned cationic surfactants can be used individually or in any combination with each other, wherein amounts between 0.01 to 20 wt.%, Preferably in amounts of 0.01 to 10 wt.% And most preferably in amounts of 0.1 to 7.5% by weight. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.
- the surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total agent used according to the invention ,
- compositions comprising the combination of active substances (A) according to the invention are characterized in that they furthermore comprise at least one native oil or at least one ester oil or at least one silicone oil or at least one polymer.
- Ester oils are to be understood as meaning the esters of C 6 - C 30 fatty acids with C 2 - C 30 fatty alcohols.
- the monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
- Examples of fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, Gadoleic acid, behenic acid and erucic acid and their technical mixtures.
- fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures.
- isopropyl myristate IPM Rilanit ®
- isononanoic acid C16-18 alkyl ester Cetiol ® SN
- 2-ethylhexyl palmitate Cegesoft ® 24
- stearic acid-2-ethylhexyl ester Cetiol ® 868
- cetyl oleate glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ® LC)
- n-butyl stearate oleyl erucate
- isopropyl palmitate IPP Rilanit ®
- oleyl Oleate Cetiol ®
- lauric acid hexyl ester Cetiol ® A
- di-n-butyl adipate Cetiol ® B
- ester oils may also be alkoxylated with ethylene oxide, propylene oxide, or mixtures of ethylene oxide and propylene oxide.
- the alkoxylation can be found both on the fatty alcohol part and on the fatty acid part and on both parts of the ester oils.
- R 1 is a saturated or unsaturated, branched or unbranched, cyclic saturated cyclic unsaturated acyl radical having 6 to 30 carbon atoms,
- AO is ethylene oxide, propylene oxide or butylene oxide
- X is a number between 1 and 200, preferably 1 and 100, more preferably between 1 and 50, most preferably between 1 and 20, most preferably between 1 and 10 and most preferably between 1 and 5,
- R 2 represents a saturated or unsaturated, branched or unbranched cyclic saturated cyclic unsaturated alkyl, alkenyl, alkynyl, phenyl or benzyl radical having from 6 to 30 carbon atoms.
- fatty acid moieties used as radical R1 in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid , Gadoleic acid, behenic acid and erucic acid and their technical mixtures.
- ester oils examples include benzyl alcohol, isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol , Elearstearyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures.
- a particularly preferred ester oil according to the invention is obtainable, for example, under the INCI name PPG-3 benzyl ether myristate.
- ester oils are to be understood as meaning:
- Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
- diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,
- Fatty acid partial glycerides ie monoglycerides, diglycerides and their technical mixtures. Typical examples are mono- and / or diglycerides based on caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, Gadoleic acid, behenic acid and erucic acid and their technical mixtures.
- oleic acid monoglycerides are used.
- the ester oils are present in the compositions according to the invention in an amount of from 0.01 to 20% by weight, preferably from 0.01 to 10.0% by weight, particularly preferably from 0.01 to 7.5% by weight, most preferably from 0, 1 to 5.0 wt.% Used.
- natural oils can additionally be used with the active ingredient combination (A) according to the invention.
- the natural oils may also be waxy or solid at room temperature.
- these oils, oil body, a melting point less than 50 0 C, more preferably less than 45 0 C, most preferably less than 40 0 C, most preferably smaller than 35 ° C and most preferably the cosmetic oils are at a temperature less than 30
- oils according to the invention include:
- oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
- the compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) - cyclohexane (Cetiol ® S), and di-n-octyl ether (Cetiol ® OE) may be preferred.
- Natural oils include, for example, amaranth seed oil, apricot kernel oil, argan oil,
- Currant seed oil jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil,
- Buckthorn seed oil sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or
- the natural oils are present in the compositions according to the invention in an amount of from 0.01 to 20% by weight, preferably from 0.01 to 10.0% by weight, particularly preferably from 0.01 to 7.5% by weight, most preferably from 0 , 1 to 5.0 wt.% Used.
- compositions according to the invention preferably contain at least one silicone polymer selected from the group of dimethiconols and / or the group of amino-functional silicones and / or the group of dimethicones and / or the group of cyclomethicones , These ingredients are described below.
- the dimethicones according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
- Linear dimethicones can be represented by the following structural formula (Sil):
- Branched dimethicones can be represented by the structural formula (SM .1): )
- the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
- the numbers x, y and z are integers and each run independently from 0 to 50,000.
- the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
- the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
- Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps. Most preferred are viscosities around the range of about 60,000 cps.
- Particularly preferred cosmetic or dermatological preparations according to the invention are characterized in that they contain at least one silicone of the formula (Sil .2)
- x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.
- the dimethicones (Sil) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, more preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5 wt.% Based on the total composition.
- Particularly preferred agents according to the invention contain one or more amino-functional silicones.
- Such silicones may e.g. by the formula (Si-2)
- R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6
- Q is a polar radical of the general formula -R 1 HZ
- R 1 is a divalent linking group bonded to hydrogen and the radical Z composed of carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms, and
- Z is an organic, amino-functional group containing at least one amino-functional group; a assumes values in the range of about 0 to about 2,
- b takes values in the range of about 1 to about 3,
- a + b is less than or equal to 3
- c is a number in the range of about 1 to about 3, and
- x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and
- y is a number in the range of from about 20 to about 10,000, preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy ,
- Z is according to formula (Si-2) an organic, amino-functional radical containing at least one functional amino group.
- a possible formula for said Z is NH (CH 2 ) z NH 2 , where z is an integer greater than or equal to 1.
- Another possible formula for said Z is -NH (CH 2 ) Z (CH 2 ) zz NH, wherein both z and zz independently of one another are an integer greater than or equal to 1, this structure comprising diamino ring structures, such as piperazinyl.
- Said Z is most preferably an -NHCH 2 CH 2 NH 2 radical.
- Z is - N (CH 2 ) Z (CH 2 ) ZZ NX 2 or -NX 2 , wherein each X of X 2 is independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.
- Q according to formula (Si-2) is most preferably a polar amino-functional radical of formula - CH 2 CH 2 CH 2 NH 2 CH 2 CH 2 NH 2 .
- ⁇ assumes values in the range of 0 to 2
- b takes values in the range of 2 to 3
- a + b is less than or equal to 3
- c is a number in the range of 1 to 3.
- cationic silicone oils such as, for example, the commercially available products Dow Corning (DC) 929 emulsion, DC 2-2078, DC 5-7113, SM-2059 (General Electric) and SLM-55067 (Wacker).
- Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si 3-a)
- n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
- silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration and are available, for example, under the name Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone).
- compositions according to the invention which contain at least one amino-functional silicone of the formula (Si-3b) R- [Si (CH 3) 2 -O] n1 [Si (R ') - O] m - [Si (CH 3) 2 -O] n2 SiMe 2 R (Si-3b),
- R is -OH, (optionally ethoxylated and / or propoxylated) (C 1 to C 20 ) -
- R ' is -OH, a (C 1 to C 20 ) alkoxy group or a -CH 3 group and
- n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2000, preferably between 50 and 150, the sum (n1 + n2) preferably having values from 0 to 1999 and in particular from 49 to 149 and m preferably assumes values of from 1 to 2000, in particular from 1 to 10.
- silicones are according to the INCI declaration as Amodimethicone, or as functionalized Amodimethicone, such as bis (C13-15 alkoxy) PG Amodimethicone (for example, as a commercial product: DC 8500 from Dow Corning available), trideceth-9 PG-amodimethicones (for example as a commercial product Silcare Silicone SEA available from Clariant).
- Suitable diquaternary silicones are selected from compounds of the general formula (Si3c)
- radicals R 7 to R 12 independently of one another, are identical or different and are C 1 to C 10 -alkyl or phenyl,
- A is a divalent organic compound group
- n is a number from 0 to 200, preferably from 10 to 120, more preferably from 10 to 40, and X 'is an anion.
- the divalent linking group is preferably a C1 to C12 alkylene or alkoxyalkylene group which may be substituted with one or more hydroxyl groups. Particularly preferred is the group - (CH 2 ) 3 -O-CH 2 -CH (OH) -CH 2 -.
- the anion X ' can be a halide ion, an acetate, an organic carboxylate or a compound of the general formula RSO 3 " , in which R has the meaning of C 1 -C 4 -alkyl radicals.
- a preferred diquaternary silicone has the general formula (Si3d)
- A is the group - (CH 2 ) 3 - O - CH 2 - CH (OH) - CH 2 -,
- R is an alkyl radical having at least 8 C atoms and n is a number from 10 to 120.
- Suitable silicone polymers having two terminal quaternary ammonium groups are known under the INCI name Quaternium-80. These are dimethylsiloxanes with two terminal trialkylammonium groups. Such diquaternary polydimethylsiloxanes are marketed by Evonik under the trade names Abil ® Quat 3270, 3272 and 3474th Cosmetic or dermatological preparations preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.01 to 8% by weight, particularly preferably 0.1 to 7.5% by weight and in particular from 0.2 to 5% by weight of amino-functional silicone (s) and / or diquaternary silicone.
- the compositions of the invention may contain at least one polyammonium-polysiloxane compound.
- the polyammonium-polysiloxane compounds can be obtained, for example, under the trade name Baysilone® from GE Bayer Silicones.
- the products with the names Baysilone TP 391 1, SME 253 and SFE 839 are preferred. Very particular preference is given to the use of Baysilone TP 3911 as the active component of the compositions according to the invention.
- the polyammonium-polysiloxane compounds are present in the compositions according to the invention in an amount of from 0.01 to 10% by weight, preferably from 0.01 to 7.5, particularly preferably from 0.01 to 5.0% by weight, very particularly preferably from 0 , 05 to 2.5 wt.% Each used in relation to the total composition.
- cyclic dimethicones designated as cyclomethicones according to INCI are also preferably used according to the invention.
- cosmetic or dermatological preparations according to the invention are preferred which contain at least one silicone of the formula (Si-4)
- x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.
- Agents which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula (Si-5)
- R stands for identical or different radicals from the group -H, -phenyl, -benzyl, -CH 2 -CH (CH 3) Ph
- the CI_ 20 -alkyl preferably -CH 3, -CH 2 CH 3, -CH 2 CH 2 CH 3 , - CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 H 3 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -C ( CH 3 ) 3
- x and y are a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and in particular 0, 1, 2, 3, 4, 5 or 6, and n is a number from 0 to 10, preferably from 1 to 8 and in particular from 2, 3, 4, 5, 6.
- water-soluble silicones may be present in the compositions according to the invention.
- hydrophilic silicones are selected, for example, from the compounds of the formulas (Si-6) and / or (Si-7).
- Particularly preferred water-soluble silicone-based surfactants are selected from the group of dimethicone copolyols which are preferably alkoxylated, in particular polyethoxylated or polypropoxylated.
- Dimethicone copolyols according to the invention are preferably polyoxyalkylene-modified
- radical R represents a hydrogen atom, an alkyl group having 1 to 12 C atoms, an alkoxy group having 1 to 12 C atoms or a hydroxyl group
- radicals R 'and R denote alkyl groups having 1 to 12 C atoms
- x is an integer from 1 to 100, preferably from 20 to 30
- y is an integer from 1 to 20, preferably from 2 to 10
- a and b are integers from 0 to 50, preferably from 10 to 30 ,
- dimethicone copolyols according to the invention are, for example, the products sold commercially under the trade names SILWET (Union Carbide Corporation) and DOW CORNING.
- Particularly preferred dimethicone copolyols according to the invention are Dow Corning 190 and Dow Corning 193.
- the dimethicone copolyols are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, more preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight. % of dimethicone copolyol based on the composition.
- the dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
- Linear dimethiconols can be represented by the following structural formula (Si8-I):
- Branched dimethiconols can be represented by the structural formula (Si8 - II):
- the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
- the numbers x, y, and z are integers and are each running independently from 0 to 50,000.
- the molecular weights of Dimethiconole lie between
- the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
- Preferred viscosities are 1000 to 5,000,000 cps, most preferred viscosities lie between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
- Examples of such products include the following commercial products: Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Coming 2-9026 Fluid, Abil OSW 5 (Degussa Care Specials), Dow Coming 1401 Fluid, Dow Corning 1403 Fluid Dow Corning 1501 Fluid, Dow Corning 1784 HVF Emulsion, Dow Corning 9546 Silicone Elastomer Blend, SM555, SM2725, SM2765, SM2785 (all four aforementioned GE Silicones), Wacker-Belsil CM 1000, Wacker-Belsil CM 3092, Wacker-Belsil CM 5040, Wacker-Belsil DM 3096, Wacker-Belsil DM 3112 VP, Wacker-Belsil DM 8005 VP, Wacker-Belsil DM 60081 VP (all Wacker-Chemie GmbH mentioned above).
- the dimethiconols (Si8) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, more preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of dimethiconol based on the composition.
- polymers for increasing the activity of the active ingredient complex (A) are included.
- the interaction of the rambutan oil with the cationic polymers leads to a particularly intensive improvement in the care properties.
- the combability of the wet and dry hair as well as the gloss are greatly improved by this combination.
- the cationic polymers may be homopolymers or copolymers wherein the quaternary nitrogen groups are contained either in the polymer chain or preferably as a substituent on one or more of the monomers.
- the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
- Suitable cationic monomers are unsaturated, free-radically polymerizable compounds which carry at least one cationic group, in particular ammonium-substituted vinyl monomers, for example trialkylmethacryloxyalkylammonium, trialkylacryloxyalkylammonium,
- Dialkyl diallyl ammonium and quaternary vinyl ammonium monomers with cyclic, cationic nitrogen-containing groups such as pyridinium, imidazolium or quaternary pyrrolidones, e.g. Alkylvinylimidazolium, Alkylvinylpyridinium, or Alyklvinylpyrrolidon salts.
- the alkyl groups of these monomers are preferably lower alkyl groups such as C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
- the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
- Suitable comonomers are, for example, acrylamide, methacrylamide; Alkyl and dialkylacrylamide, alkyl and dialkylmethacrylamide, alkyl acrylate, alkyl methacrylate, vinylcaprolactone, vinylcaprolactam, vinylpyrrolidone, vinyl esters, for example vinyl acetate, vinyl alcohol, propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers preferably C1 to C7 alkyl groups, particularly preferably C1 to C3 Alkyl groups are.
- Suitable polymers with quaternary amine groups are, for example, those in CTFA Cosmetic
- Methylvinylimidazolium chloride / vinylpyrrolidone copolymer (Polyquaternium-16) or quaternized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Polyquaternium-1 1).
- cationic polymers for example vinylpyrrolidone / dimethylaminoethyl copolymer available under the trade names Gafquat ® 755 N and Gafquat ® 734, United States is marketed by Gaf Co. and of which the Gafquat ® 734 is particularly preferred suitable.
- Further cationic polymers are, for example, those of the company BASF, Germany under the
- Vinyl pyrrolidone / methacrylamidopropyl trimethyl ammonium chloride copolymer Vinyl pyrrolidone / methacrylamidopropyl trimethyl ammonium chloride copolymer.
- R 1 is -H or -CH 3
- R 2 , R 3 and R 4 are independently selected from C 1-4 -alkyl.
- Alkyl, alkenyl or hydroxyalkyl groups, m 1, 2, 3 or 4, n is a natural number and
- Polymers are those inventively preferred for which at least one of the following
- R 1 is a methyl group
- R 2 , R 3 and R 4 are methyl groups
- m is 2.
- a physiologically acceptable counterion X come, for example, halide ions,
- Tartrate and acetate ions into consideration. Preference is given to halide ions, in particular chloride.
- a particularly suitable homopolymer is, if desired, crosslinked,
- the homopolymer is preferably used in the form of a non-aqueous polymer dispersion.
- Such polymer dispersions are available under the names Salcare ® SC 95 and Salcare ® SC 96 in the trade.
- a preferred copolymer according to the invention is the crosslinked acrylamide
- Methacryloyloxyethyltrimethylammonium chloride copolymer is commercially available under the name Salcare ® SC 92nd
- Suitable cationic polymers derived from natural polymers are cationic ones
- Cationic polysaccharides have the general formula (P-3) GOB-N + R a R b R c X "
- G is an anhydroglucose residue, for example starch or cellulose anhydroglucose
- B is a divalent linking group, for example alkylene, oxyalkylene, polyoxyalkylene or
- R a , R b and R c are independently alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl or
- Alkoxyaryl each having up to 18 carbon atoms, wherein the total number of carbon atoms in R a , R b and R c is preferably not more than 20;
- X " is a common counteranion and is preferably chloride.
- a cationic cellulose is sold under the name Polymer JR 400 from Amerchol ® and has the INCI designation Polyquaternium-10 degrees.
- Another cationic cellulose bears the INCI name Polyquaternium-24 and is sold under the trade name Polymer LM-200 by Amerchol.
- Other commercial products are the compounds Celquat ® H 100, Celquat ® L and 200. The commercial products mentioned are preferred cationic celluloses.
- Suitable cationic guar derivatives are marketed under the trade name Jaguar ® and have the INCI name guar hydroxypropyltrimonium chloride. Further particularly suitable cationic guar derivatives are also used by the company. Hercules under the name N-Hance ® commercially. Other cationic guar derivatives are marketed by the company. Cognis under the name Cosmedia® ®. A preferred cationic guar derivative is the commercial product AquaCat® ® from. Hercules. This raw material is an already pre-dissolved cationic guar derivative.
- a suitable chitosan is sold, for example, by Kyowa Oil & Fat, Japan under the trade name Flonac ®.
- a preferred chitosan is chitosoniumpyrrolidone is, for example, sold under the name Kytamer ® PC by Amerchol, USA.
- Further chitosan derivatives are Hydagen® ® CMF, Hydagen® ® HCMF and Chitolam ® NB / 101 freely available under the trade names in the trade.
- honey for example the commercial product Honeyquat ® 50,
- Vinylpyrrolidone vinylimidazoliummethochloride copolymers such as those offered under the names Luviquat.RTM ® FC 370, FC 550, FC 905 and HM 552,
- Vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers such as those offered with acrylic acid esters and acrylamides as the third monomer building commercially, for example, under the name Aquaflex ® SF 40.
- copolymers of vinylpyrrolidone as they are known as
- Copolymer 845 manufactured by ISP
- Gaffix ® VC 713 manufactured by ISP
- Gafquat ® ASCP 1011 Gafquat ® HS 110 Luviquat.RTM ® 8155 and Luviquat.RTM ® MS are available 370th
- cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates.
- cationic protein hydrolysates and derivatives those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 th Street, NW, Suite 300 Washington, DC 20036-4702) and commercially available products.
- the cationic polymers are contained in the compositions according to the invention preferably in amounts of 0.01 to 10 wt .-%, based on the total agent. Levels of 0.05 to 5 wt .-% are particularly preferred.
- amphoteric polymers can be used as polymers.
- amphoteric polymers includes both those polymers which contain in the molecule both free amino groups and free -COOH or SO 3 H groups and are capable of forming internal salts, as well as zwitterionic polymers which in the molecule have quaternary ammonium groups and -COO or -SO 3 ⁇ groups, and those polymers comprising -COOH or SO 3 H groups and quaternary ammonium groups.
- Amphoteric and / or cationic polymers preferred according to the invention are those polymers in which a cationic group is derived from at least one of the following monomers:
- R 1 -CH CR 2 -CO-Z- (C n H 2n ) -N (+) R 2 R 3 R 4 A () (monol)
- R 1 and R 2 independently of one another are hydrogen or a methyl group and R 3 , R 4 and R 5 independently of one another are alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer of 2 to 5 and A () is the anion of an organic or inorganic acid,
- R 6 and R 7 are independently a (C 1 to C 4 ) alkyl group, in particular a methyl group and
- R 8 -CH CR 9 -COOH (mono 3)
- R 8 and R 9 are independently hydrogen or methyl groups.
- Particularly preferred are those polymers in which monomers of type (i) are used in which R 3 , R 4 and R 5 are methyl groups, Z is an NH group and A () is a halide,
- Methoxy sulfate or ethoxy sulfate ion; Acrylamidopropyltrimethylammonium chloride is a particularly preferred monomer (i).
- acrylic acid is preferably used as the monomer (ii) for the polymers mentioned.
- amphoteric polymers are copolymers of at least one monomer
- Monomers (Mono2) and (Mono3) are copolymers of diallyl dimethyl ammonium chloride and acrylic acid.
- copolymers are sold under the INCI name Polyquaternium-22, among others, with the trade name Merquat ® 280 (Nalco).
- amphoteric polymers of the invention may be used in addition to a monomer
- R 10 and R 11 are independently hydrogen or methyl groups and R 12 is a hydrogen atom or a (C 1 to C 8 ) alkyl group.
- Amphoteric polymers based on a comonomer (Mono4) which are very particularly preferably used according to the invention are terpolymers of diallyldimethylammonium chloride, acrylamide and acrylic acid. These copolymers are marketed ® under the INCI name Polyquaternium-39, among others, with the trade name Merquat Plus 3330 (Nalco).
- amphoteric polymers can generally be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention.
- amphoteric polymers are contained in the agents according to the invention preferably in amounts of 0.01 to 10 wt .-%, based on the total agent. Amounts of 0.01 to 5 wt .-% are particularly preferred.
- the anionic polymers are anionic polymers which have carboxylate and / or sulfonate groups.
- anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
- the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
- Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
- Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for the sulfonic acid group to be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,
- the homopolymer of 2-acrylamido-2-acid methylpropansulfon available for example under the name Rheothik ® 11-80 is commercially.
- copolymers of at least one anionic monomer and at least one nonionic monomer are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.
- Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
- Simulgel ® 600 as a compound with isohexadecane and polysorbate 80 Natriumacryloyldimethyltaurat copolymers have proven to be particularly effective according to the invention.
- anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially.
- Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers.
- a 1, 9-decadiene crosslinked maleic acid-methyl vinyl ether copolymer is available under the name ® Stabileze QM.
- the anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
- the agents according to the invention may contain nonionogenic polymers.
- Suitable nonionic polymers are, for example:
- Vinylpyrrolidone / vinyl ester copolymers as sold, for example, under the trademark Luviskol ® (BASF).
- Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
- Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy-, as sold for example under the trademark Culminal® ® and Benecel ® (AQUALON) and Natrosol ® grades (Hercules).
- Starch and its derivatives in particular starch, such as Structure XL ® (National Starch), a multifunctional, salt-tolerant starch;
- the nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred. It is also possible according to the invention that the preparations used contain a plurality, in particular two, different polymers of the same charge and / or in each case an ionic and an amphoteric and / or nonionic polymer.
- the polymers (P) are preferably present in the compositions used according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition. Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred.
- compositions of the invention may further contain conventional ingredients in cosmetic compositions.
- Emulsifiers which can be used according to the invention are, for example
- Alkylphenols having 8 to 15 C atoms in the alkyl group having 8 to 15 C atoms in the alkyl group
- Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
- Sterols both from animal tissue (zoosterols, cholesterol, lanosterol) as from vegetable fats (phytosterols, ergosterol, stigmasterol, sitosterol) or from fungi and
- Phospholipids lecithins, phopshatidylcholines
- Fatty acid esters of sugars and sugar alcohols such as sorbitol
- Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate
- the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
- fatty acids can be used linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ® 871 and Emersol ® 875, and isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
- fatty acids are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myrotic acid, ristinic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid,
- Petroselinic acid linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures.
- Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.
- the amount used is 0.1 - 15 wt.%, Based on the total mean.
- the amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.
- fatty alcohols fatal
- saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 -C 30 -, preferably C 10 -C 22 -and very particularly preferably C 12 -C 22 -carbon atoms.
- Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character.
- the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction.
- those fatty alcohol cuts which represent a mixture of different fatty alcohols.
- Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD-Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or acquire Is
- wool wax alcohols as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used according to the invention.
- the fatty alcohols are used in amounts of from 0.1 to 30% by weight, based on the total preparation, preferably in amounts of from 0.1 to 20% by weight.
- waxes As natural or synthetic waxes (Fatwax), solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP can be used according to the invention.
- Such waxes are available, for example, from Kahl & Co., Trittau.
- the amount used is 0.1-50 wt.% Based on the total agent, preferably 0.1 to 20 wt.% And particularly preferably 0.1 to 15 wt.% Based on the total agent.
- the total amount of oil and fat components in the compositions according to the invention is usually 0.5-75% by weight, based on the total agent. Amounts of 0.5-35 wt .-% are preferred according to the invention.
- Another inventive synergistic active ingredient in the compositions according to the invention with the active ingredient complex according to the invention are protein hydrolysates and / or derivatives thereof (P).
- protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
- Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
- Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois ® (Interorgana)
- Lexein ® Inolex
- kerasol tm ® (Croda) sold.
- Soy, almonds, peas, moringa, potato and wheat protein hydrolysates are, for example, under the trademarks Gluadin ® (Cognis), diamine ® (Diamalt) ®
- protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of
- casein is used as the protein hydrolyzate.
- casein in the compositions together with rambutan oil leads to sensory and noticeable haptic effects on the skin and the hair.
- the hair treated with it feels much stronger and stronger due to its haptic properties.
- the surface is smooth and supple, and on the other hand, the coverage of the surface with the active ingredient combination is still noticeable.
- the protein hydrolysates (P) are in the compositions in concentrations of 0.001
- % By weight up to 20% by weight, preferably from 0.05% by weight up to 15% by weight and very particularly preferably in amounts of from 0.05% by weight up to 5% by weight.
- compositions according to the invention are from 0.05 to 10% by weight, based on the total composition, particularly preferably from 0.1 to 5, and in particular
- compositions according to the invention with the active ingredient complex according to the invention are vitamins, provitamins or vitamin precursors.
- Vitamins, pro-vitamins and vitamin precursors are particularly preferred to the groups
- A, B, C, E, F and H are assigned.
- vitamin A includes retinol (vitamin A 1 ) and 3,4-didehydroretinol (vitamin A 2 ).
- the ß-carotene is the provitamin of retinol.
- a component according to the invention for example, vitamin A acid and its esters,
- Vitamin A aldehyde and vitamin A alcohol and its esters such as palmitate and acetate in Consideration preferably contain the vitamin A component in
- the vitamin B group or the vitamin B complex include u. a .:
- Vitamin B 1 (thiamine)
- Vitamin B 2 (riboflavin)
- Vitamin B 3 Under this designation are often the compounds nicotinic acid and
- Nicotinic acid amide (niacinamide).
- Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.
- Vitamin B 5 pantothenic acid, panthenol and pantolactone. Panthenol and / or pantolactone are preferably used in the context of this group. Usable according to the invention
- panthenol Derivatives of panthenol are in particular the esters and ethers of panthenol as well as cationically derivatized panthenols. Individual representatives are, for example, panthenol triacetate, the
- Panthenol monoethyl ether and its monoacetate and cationic panthenol derivatives Panthenol monoethyl ether and its monoacetate and cationic panthenol derivatives.
- Pantothenic acid is preferred as a derivative in the form of the more stable calcium salts and sodium salts
- Vitamin B 6 pyridoxine and pyridoxamine and pyridoxal.
- the said compounds of the vitamin B type are preferably present in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.
- Vitamin C (ascorbic acid). Vitamin C is preferred in the agents according to the invention.
- Vitamin E tocopherols, especially ⁇ -tocopherol.
- Tocopherol and its derivatives which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.
- Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
- Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed.
- Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.
- compositions according to the invention preferably contain vitamins, provitamins and
- Derivatives as well as nicotinic acid amide and biotin are particularly preferred.
- compositions are the betainees mentioned below: carnitine, carnitine tartrate, carnitine
- Carnitine, histidine, choline and betaine are preferably used.
- the active ingredient used is L-carnitine tartrate.
- taurine is exclusively 2-aminoethanesulfonic acid and a derivative is understood to mean the explicitly mentioned derivatives of taurine.
- Derivatives of taurine include N-monomethyltaurine, N, N-dimethyltaurine, tauryllysylate, taurine tartrate, taurine ornithithate, lysyl taurine and ornithyl taurine.
- Further taurine derivatives for the purposes of the present invention are taurocholic acid and hypotaurine.
- agents according to the invention which - based on their weight - 0.0001 to 10.0 wt .-%, preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and In particular, 0.001 to 1, 0 wt .-% taurine and / or a derivative of taurine included.
- the compositions according to the invention contain biochinones.
- suitable biochinones are understood as meaning one or more ubiquinone (s) and / or plastoquinone (s).
- the preferred ubiquinones according to the invention have the following formula:
- Coenzyme Q-10 is most preferred.
- compositions of the invention contain purine and / or purine derivatives in narrower ranges.
- preferred cosmetic compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
- Cosmetic agents preferred according to the invention are characterized in that they contain purine, adenine, guanine, uric acid, hypoxanthine, 6-purinethiol, 6-thioguanine, xanthine, caffeine, theobromine or theophylline. In hair cosmetic preparations, caffeine is most preferred.
- the cosmetic agent contains ectoine ((S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid.
- agents which, based on their weight, are from 0.00001 to 10.0% by weight, preferably from 0.0001 to 5.0% by weight and in particular from 0.001 to 3% by weight, of the active compounds from A group formed by carnitine, taurine, coenzyme Q-10, ectoine, a B-series vitamin, a purine and its derivatives or physiologically acceptable salts.
- the agents according to the invention should additionally contain at least one UV light protection filter.
- UVB filters can be oil-soluble or water-soluble.
- oil-soluble substances are: 3-benzylidene camphor, eg 3- (4-methylbenzylidene) camphor;
- 4-aminobenzoic acid derivatives preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and A-
- esters of cinnamic acid preferably 2-ethylhexyl 4-methoxycinnamate, A-
- Esters of salicylic acid preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate;
- Esters of benzalmalonic acid preferably di-2-ethylhexyl 4-methoxybenzmalonate
- Triazine derivatives e.g. 2,4,6-Trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine and
- Propane-1,3-diones e.g. 1- (4-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione;
- Suitable water-soluble substances are:
- Sulfonic acid derivatives of the 3-benzylidene camphor e.g. 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) -sulfonic acid and its salts.
- UV-A filter in particular derivatives of benzoylmethane come into question, such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione or 1-phenyl-3 (4'-isopropylphenyl) -propane-1,3-dione.
- the UV-A and UV-B filters can also be used in mixtures.
- insoluble pigments are also suitable for this purpose, in particular finely dispersed metal oxides or salts, for example titanium dioxide, zinc oxide, iron oxide, aluminum oxide, cerium oxide, zirconium oxide, silicates (talc), barium sulfate and zinc stearate.
- the particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They may have a spherical shape, but it is also possible to use those particles which have an ellipsoidal or otherwise deviating shape from the spherical shape.
- plant extracts (L) in the compositions according to the invention gives rise to further advantages.
- the plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.
- the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as
- Structurants such as maleic acid and lactic acid
- Swelling agents such as urea, allantoin, carbonates or hydantoin
- Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
- Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
- Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
- Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
- Another subject of the invention is a hair treatment process in which a cosmetic composition according to claim 1 is applied to the hair and is rinsed by the hair after a contact time.
- the exposure time is preferably a few seconds to 100 minutes, more preferably 1 to 50 minutes and most preferably 1 to 30 minutes. Examples:
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE200910028538 DE102009028538A1 (de) | 2009-08-14 | 2009-08-14 | Zusammensetzungen zur Haarpflege enthaltend Rambutanöl |
PCT/EP2010/059623 WO2011018278A2 (de) | 2009-08-14 | 2010-07-06 | Zusammensetzungen zur haarpflege enthaltend rambutanöl |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2464329A2 true EP2464329A2 (de) | 2012-06-20 |
Family
ID=43448078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10731509A Ceased EP2464329A2 (de) | 2009-08-14 | 2010-07-06 | Zusammensetzungen zur haarpflege enthaltend rambutanöl |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2464329A2 (de) |
DE (1) | DE102009028538A1 (de) |
WO (1) | WO2011018278A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3069779A1 (fr) | 2017-08-02 | 2019-02-08 | Basf Beauty Care Solutions France Sas | Utilisation d'un extrait de pericarpe de nephelium lappaceum pour hydrater la peau et/ou les muqueuses |
WO2019025724A1 (fr) | 2017-08-02 | 2019-02-07 | Basf Beauty Care Solutions France Sas | Nouvelle utilisation cosmetique d'un extrait de nephelium lappaceum |
FR3077493B1 (fr) | 2018-01-16 | 2022-06-10 | Basf Beauty Care Solutions France Sas | Nouvelle utilisation cosmétique d’un extrait de Nephelium lappaceum |
EP3941435A1 (de) | 2019-03-21 | 2022-01-26 | BASF Beauty Care Solutions France SAS | Neue nicht-therapeutische verwendung eines extrakts von nephelium lappaceum zur verhinderung und/oder verringerung von unangenehmen gerüchen auf der haut und/oder schleimhäuten und/oder hautanhangsgebilden |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2762007B1 (fr) * | 1997-04-11 | 2002-08-02 | Fabre Pierre Dermo Cosmetique | Extrait d'huile de macassar, son obtention et son utilisation en cosmetologie |
DE102007001028A1 (de) * | 2007-01-02 | 2008-07-03 | Henkel Kgaa | Kosmetische Zusammensetzung enthaltend Arganöl und Sheabutter |
DE102008046207A1 (de) * | 2008-09-08 | 2010-06-17 | Henkel Ag & Co. Kgaa | Natürliches Haarbehandlungsmittel |
-
2009
- 2009-08-14 DE DE200910028538 patent/DE102009028538A1/de not_active Withdrawn
-
2010
- 2010-07-06 EP EP10731509A patent/EP2464329A2/de not_active Ceased
- 2010-07-06 WO PCT/EP2010/059623 patent/WO2011018278A2/de active Application Filing
Non-Patent Citations (1)
Title |
---|
See references of WO2011018278A2 * |
Also Published As
Publication number | Publication date |
---|---|
DE102009028538A1 (de) | 2011-02-17 |
WO2011018278A3 (de) | 2012-06-28 |
WO2011018278A2 (de) | 2011-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2528582A2 (de) | Haarkonditionierende mittel mit ausgewählten kationischen siliconen und dimethicon | |
WO2010018047A2 (de) | Kosmetische zusammensetzung enthaltend öl aus den früchten der sumachgewächse | |
DE102012203240A1 (de) | Haarpflegemittel mit Antischuppenmitteln und ausgewählten Aminosilikonen | |
WO2013072163A2 (de) | Haarpflegemittel mit antischuppenmitteln und kationischen silikonen | |
EP2724710A2 (de) | Haarpflegemittel mit kationischen Alkyloligoglucosiden und Polyglycerinestern | |
WO2011009710A2 (de) | Haarkonditionierende mittel mit kationischen imidazolinen und ausgewählten kationischen siliconen | |
WO2011036169A2 (de) | Mittel zur behandlung keratinischer fasern enthaltend dimethylsilanol hyaluronate und glycerin | |
EP2464329A2 (de) | Zusammensetzungen zur haarpflege enthaltend rambutanöl | |
WO2013143780A1 (de) | Haarbehandlungsmittel enthaltend ausgewählte fettsäureamide und ausgewählte silikone | |
WO2011020646A2 (de) | Zusammensetzungen zur haarpflege enthaltend lanolinalkohol mit einem hohen gehalt langkettiger fettalkohole | |
EP2724714A2 (de) | Klares Pflegespray mit gesteigerter Leistung | |
EP2822658A2 (de) | Haarkur ohne arylierte silikone | |
DE102009028537A1 (de) | Zusammensetzungen zur Haarpflege enthaltend natürliche Öle mit hohen Anteilen gesättigter Fettsäuren | |
WO2013072156A2 (de) | Haarpflegemittel mit ausgewählten kationischen verbindungen und kationischen silikonen | |
EP2882409A2 (de) | Haarpflegemittel mit antischuppenmitteln und ausgewählte komplexe aus sauren proteinhydrolysaten und basischen fettsäureamidoaminen | |
EP2571480A2 (de) | Haarbehandlungsmittel mit polyquaternium-72 | |
WO2013079313A2 (de) | Haarpflegemittel mit polyquaternium-71 und kationischen silikonen | |
EP2809296A2 (de) | Haarpflegemittel mit ausgewählten kationischen alkyloligoglucosiden und weiteren quaternären ammoniumverbindungen | |
DE102009027942A1 (de) | Haarbehandlungsmittel enthaltend einen Extrakt aus Cimicifuga | |
WO2011009713A2 (de) | Kosmetische zusammensetzung enthaltend ethoxyliertes amaranthöl | |
WO2011009711A2 (de) | Haarkonditionierende mittel mit ausgewählten kationischen siliconen und einem vitamin der b-reihe | |
DE102009027943A1 (de) | Haarbehandlungsmittel mit Kokum Butter | |
WO2014023491A2 (de) | Haarbehandlungsmittel enthaltend ausgewählte quaternäre ammoniumverbindungen und ausgewählte komplexe aus sauren proteinhydrolysaten und basischen fettsäureamidoaminen | |
WO2013079278A2 (de) | Haarpflegemittel mit ausgewählten kationischen alkyloligoglucosiden und kationischen silikonen | |
WO2013127613A2 (de) | Haarpflegemittel mit ausgewählten kationischen alkyloligoglucosiden und ausgewählten kationischen silikonen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120120 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
R17D | Deferred search report published (corrected) |
Effective date: 20120628 |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20141219 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20150406 |